ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Afqlir 40 mg/ml, Injektionslösung in einer Fertigspritze - 
70126001 Sandoz Pharmaceuticals AG
Afqlir 40 mg/ml, Injektionslösung in einer Fertigspritze25.09.2025
  25.09.2025
Aflibercept (S01LA05) 
WHO-DDD24.09.2030
11.99. 
11.99. 
B  
Yes 
IP 
549.84Yes
    
10 %614.40
  
7680701260014Biotechnologika
  
Composition
afliberceptum 2 mg, histidinum, histidini hydrochloridum monohydricum, trehalosum dihydricum, polysorbatum 20, acidum hydrochloridum, natrii hydroxidum, aqua ad iniectabile, ad solutionem pro 50 µl corresp. natrium 1.73 µg.
Packungsbestandteile
Injection solution in prefilled syringe 
  
 
Active AgentDose
Afliberceptum2mg / 50µl
BAG: Active AgentDose
Afliberceptum2 mg
 
Inactive agents
Acidum Hydrochloridum
Histidin Hydrochloride Monohydrate
Histidine
Sodium Hydroxide
Polysorbatum 20
Trehalosum Dihydricum
 
Source
Data was imported : 19.11.2025 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2025 ©ywesee GmbH
Settings | Help | Login | Contact | Home